By Yeesirn Khew-Goodall, Carolyn M. Butcher, Marek S. Litwin, Sarah Newlands, Eija I. Korpelainen, Leanne M. Noack, Michael C. Berndt, Angel F. Lopez, Jennifer R. Gamble, and Mathew A. Vadas P-selectin expressed on the surface of endothelium mediates leukocyte adhesion in vitro and rolling in vivo. Several inducers of cell-surface P-selectin expression on endothelial cells (EC) have previously been identified, all of which yield transient cell-surface expression of P-selectin lasting minutes to a few hours. We now show that a T-lymphocyte product, interleukin-3 (IL-3). stimulates the long-term expression of P-selectin on cultured human umbilical vein endothelial cells (HUVEC). IL-3 induced cell-surface P-selectin expression in two phases. An initial peak at 10 minutes was followed by a prolonged upregulation beginning 16 hours after IL-3 addition and lasting at least 4 days. The level of Pselectin expression induced by IL-3 added for 48 hours was similar to that induced by treatment of H U M C for 10 minutes with thrombin, and the effect of adding IL-3 for 48 hours followed by thrombin for 10 minutes was additive.
HE CELLULAR COMPONENTS of inflammation are
derived from the blood and migrate into tissues by a complex process involving rolling, adhesion, and transmigration. ' The selectins mediate rolling and are essential adhesion molecules for the development of inflammation.' There are three members in the selectin family, two of which, E-and P-selectin, are expressed on human umbilical vein endothelial cells (HUVEC) after stimulation. The importance of P-selectin in mediating rolling and subsequent leukocyte recruitment during inflammation is evidenced by the lack of rolling in mesenteric vessels and delayed extravasation of neutrophils into the peritoneal cavity in P-selectin knockout mice during experimentally induced inflammation. ' E-selectin expression is upregulated after stimulation by cytokines such as interleukin (1L)-l, tumor necrosis factor a (TNFa),"6 and, as has been shown more recently, IL-3,7.' with peak expression occumng between 4 and 6 hours after addition of stimulus. In contrast, cell surface expression of Pselectin can be rapidly induced by agents such as histamine, thrombin, and phorbol myristate acetate (PMA)?'" with peak expression occurring at approximately 10 minutes after addition of stimulus. Upregulation of cell-surface E-selectin expression is the result of transcriptional activation of the E-Induction of cell-surface P-seiectin expression by IL-3 was blocked by pretreatment of EC with a blocking monoclonal antibody against the IL-3 receptor a-chain. Lipopolysaccharide (LPS), tumor necrosis factor a (TNFa), and a mutant form of IL-3 with decreased potency did not induce cellsurface P-selectin expression after 48 hours' incubation with HUVEC, suggesting that the effect was specific to IL-3. The increase in cell-surface P-selectin expression occurring after 16 hours of incubation with IL-3 was accompanied by a similar prolonged increase in the steady-state mRNA level that was not observed at 10 minutes after IL-3 addition. As Tlymphocyte infiltration is a hallmark of chronic inflammation, our observations suggest that the secretion of IL-3 by T lymphocytes may serve to maintain the inflammatory state during chronic inflammation.
0 1996 by The American Society of Hematology.
selectin gene, whereas P-selectin is stored in granules in endothelial cells (EC) called Weibel-Palade bodies. The existence of a preformed pool of P-selectin, therefore, enables it to be rapidly translocated to the cell surface (within 5 to 10 minutes) after stimulation, suggesting an important role for this molecule in acute inflammation.
Other agonists such as oxygen radicals can induce a different time-course of P-selectin expression on HWEC, with a peak at about 2 to 4 hours after addition of stimulus." In mouse EC, TNFa has also been shown to induce both mRNA and cell-surface P-selectin expression with similar kinetics to that of E-selectin induction." In mice injected with lipopolysaccharide (LPS), P-selectin mRNA levels were found to be induced with a peak at about 4 hours postinjection.13 These studies demonstrate that the kinetics of P-selectin expression and whether cellular mRNA levels are altered depends on the agonist used, which may reflect the physiologic role of P-selectin in vivo.
IL-3, a product of mature T cells and mast cells14~" after activation, is classically described as a hematopoietic growth factor. However, it has recently been recognized as an endothelial cell a c t i~a t o r~.~ and may play a role in inflammation. HUVEC express high affinity IL-3 receptors the expression of which is increased after stimulation with TNFa, IL-lp, or LPS.' IL-3 binding to its receptor on HUVEC resulted in enhanced IL-8 production by HUVEC, increased E-selectin expression, and neutrophil transmigration in vitro.',' Although the factors giving rise to acute expression of selectins is well understood, the molecular mechanism of prolonged or chronic selectin expression is as yet not known. As T cells are typically involved in chronic inflammation, we hypothesize that IL-3 may be a mediator of chronic inflammation.
In this report, we show that IL-3 increased the expression of cell-surface P-selectin on HUVEC, with peak expression occurring at 10 minutes and a prolonged plateau of upregulated expression from 16 hours to at least 4 days after the addition of IL-3. The second phase of cell-surface P-selectin expression, but not the initial peak, was accompanied by an increase in the steady-state P-selectin mRNA level. These observations suggest that IL-3-mediated upregulation of P-. selectin may participate in both acute and chronic inflammation.
MATERIALS AND METHODS
Culture of HUVEC. HUVEC were extracted by collagenase treatment according to a modified version of that of Wall et a l . 1 6 Cells were grown in 25-cm2, gelatin-coated tissue culture flasks (Costar, Cambridge, MA) in endotoxin-free M199 medium (Cytosystems, Sydney, Australia), 20% fetal calf serum (FCS) (PA Biological, Sydney, Australia), 20 mm01 L" HEPES with sodium pyruvate, nonessential amino acids, and Fungizone at 37°C in a 5% CO2 atmosphere. Cells were used 2 to 5 days after establishment of culture by harvesting with trypsin (0.05%)-EDTA (0.02%) (Multicel, Trace Biosystems, Australia) for replating. After replating, endothelial cell growth supplement (Collaborative Research, Bedford, MA) at 25 mg mI" and heparin were included in the culture medium. All reagents used in the growth and passaging of HUVEC were made up under endotoxin-free conditions and contained between 10 and 100 pg mI" endotoxin using the limulus amoebocyte assay.
Flow cytometry to detect cell-surjme P-selectin expression. After IL-3 stimulation at various times after plating, HUVEC were removed at the end of the experiment with trypsin-EDTA and washed twice with fresh medium. Cells were then incubated on ice with a rabbit polyclonal antibody (Ab) against human platelet Pselectin17 at 10 pg mI-l in the presence of 0.02% (wt/vol) azide, 5% newborn calf serum for 30 minutes. The polyclonal P-selectin Ab used bound specifically to P-selectin and did not crossreact with E-selectin expressed on the surface of Chinese hamster ovary (CHO) cells transfected with the E-selectin cDNA (data not shown). Cells were washed twice at 4°C before the addition of fluorescein isothiocyanate (HTC)-conjugated sheep anti-rabbit IgG Fab2 secondary Ab (Menus, Victoria, Australia) at a 1:80 dilution. The cells were incubated on ice for 30 minutes, washed once, and then fixed in 1% formaldehyde, 2% (wthol) glucose and 0.02% (wt/vol) sodium azide in phosphate-buffered saline (PBS). Flow cytometry was performed using an EPICS Profile 11 (Coulter, Hialeah, FL); 10,OOO cells per group were analyzed.
H W E C were also stained with several anti-P-selectin monoclonal antibodies (MoAbs): AK6" (commercially available from Cymbus Bioscience, Hampshire, UK), CRC 81 (gift from Dr A. Lazirov), and P5E8 (made by immunizing mice with purified human platelets). P5E8 was shown to be specific for P-selectin by positive staining on P-selectin-transfected CH0 cells and negative staining on nontransfected, L-selectin-transfected, or E-selectin-transfected CH0 cells and the surface of resting EC (C.M.B. and Y.K.-G., unpublished observations, October 1993). Hybridoma supernatant was used for staining. MoAb binding was detected using an FITCconjugated sheep anti-mouse IgG secondary Ab. The anti-L-selectin MoAb DREG 56 was obtained from American Type Culture Collection (ATCC; Rockville, MD).
RNase protection assay to detect P-selectin mRNA. A 422-bp fragment of P-selectin cDNA (a gift from Dr G. Larsen, Genetics Institute, Boston, MA) from nucleotides (nt) 2097 to 2519" was subcloned into the vector pGEM-l. The plasmid was linearized and transcribed using l7 RNA polymerase in the presence of "P-uridine triphosphate (UTP) as described" to generate a full-length cRNA probe of 470 bases that would protect a fragment of 422 bases when hybridized to the transmembrane domain containing mRNA. A human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cRNA probe containing 103 complementary nt to the human GAPDH mRNA was used as an internal standard. The specific radioactivity of the GAPDH probe used was 40 times lower than that of4 the P-selectin probe.
Total RNA from HUVEC was isolated as previously described;" 10 pg of HUVEC total RNA was hybridized to both the P-selectin and GAPDH cRNA probes, followed by digestion with 40 pg mL" RNase A, essentially as described.20 The resulting protected fragments were resolved by electrophoresis on 6% polyacrylamide gels containing 8 mol L" urea. The molecular weight markers used were 32P-labeled pUC 19 DNA digested with Hpu 11. The amount of radioactivity in each band was visualized using a phosphorimager and quantified using ImageQuant software (Molecular Dynamics, Sunnyvale, CA). The level of P-selectin mRNA expression was calculated as a ratio of GAPDH mRNA expression.
IL-3, mutant IL-3, thrombin, andpolymyxin B suvate. Recombinant human IL-3 was from Genetics Institute and contained less than 100 pg m I -l LPS as judged by the limulus amoebocyte assay. The recombinant mutant IL-3, m47, was expressed and purified from Escherichia coli as previously described?' Human thrombin and polymyxin B sulfate were obtained from Sigma Chemical CO (St Louis, MO), and LPS (E coli 055:b5 Westphal) was from Difco Laboratories (Detroit, MI).
RESULTS
Time course of IL-3 induction of cell-su~ace P-selectin expression on HUVEC. We have previously shown that unstimulated HUVEC expressed substantial amounts of IL-3R a-and P-chain mRNAs. We show here by flow cytometry using a rabbit anti-human P-selectin polyclonal Ab that addition of IL-3 to first-passage HUVEC resulted in a timedependent increase in cell-surface expression of P-selectin (Fig 1) . The time course of P-selectin expression showed two distinct phases of induction by L-3: an early or acute phase that occurred very rapidly and peaked within 10 minutes of IL-3 addition (Fig 1, inset) and a late phase that began at about 16 hours after IL-3 addition and lasted at least 4 days. A typical flow cytometry profile showing the increase in P-selectin expression after 48 hours of incubation with IL-3 is shown in Fig 2A. A similar increase in P-selectin expression was also observed using three different MoAbs against P-selectin (Table 1) . A typical flow cytometry profile using MoAb AK6, which is very similar to that obtained using the polyclonal Ab, is shown in Fig 2B. The mean (? SEM) fold induction above basal was 1.52 +-0.07 (n = 15) at 10 minutes and 1.91 2 0.11 (n = 12) at 48 hours, and both increases were significantly above that of basal P-selectin expression. The same pattern of induction was also observed using HUVEC plated in the absence of heparin and growth factor (data not shown). The increases in cell-surface P-selectin expression induced by IL-3 at 10 minutes (Figs 1 and 4 ) and 48 hours (Fig 1) were reproducible and comparable in extent to the upregulation observed 10 minutes after the addition of thrombin (Fig 4) , PMA, or histamine as inducer^.^ We have also investigated the effect of IL-3 stimulation for 48 hours in primary HUVEC. In these experiments, HU-VEC were plated directly onto 24-well trays immediately after explant and grown until a confluent monolayer was established (usually between 3 and 5 days). Cells were then either left unstimulated, stimulated with IL-3 for 48 hours, or stimulated with thrombin for 10 minutes, followed by fixation in 1% paraformaldehyde for 10 minutes at room use only. temperature. After fixation, adherent cells were incubated with primary Ab and detected using '251-protein A. Using this approach to detect cell-surface P-selectin expression, we observed a 3.3-2 0.5-fold (mean -C SEM; n = 3) induction with thrombin (10 minutes) and 1.9-2 0.4-fold (mean -C SEM; n = 3) induction with IL-3 (48 hours), which is not significantly different from that induced by thrombin ( P = .l). We, therefore, concluded from these data that (1) thrombin and IL-3 stimulate cell-surface P-selectin expression to a similar extent in both primary and first-passage HUVEC, (2) a similar fold induction was elicited by each agonist used, whether the cells were stained unfixed in suspension on ice in the presence of azide or stained while still adherent after fixation, and (3) trypsinization of the cells before staining did not appear to influence the level of induction of cellsurface P-selectin by L-3. For all subsequent experiments described, cell-surface P-selectin expression was detected by flow cytometry of cells stained in suspension.
Specijicity of P-selectin upregulation induced by IL-3 at 48 hours. The induction of P-selectin expression at 10 min- Utes and 48 hours after IL-3 addition was inhibited significantly by a blocking anti-IL-3R a-chain MoAb, 7.G3 (Fig  3) , whereas an isotype-matched irrelevant Ab had no significant effect. To further establish that the upregulation of cell-surface P-selectin at 48 hours was specific to IL-3, we also examined the effect of incubating HUVEC for 48 hours with TNFa; a mutant IL-3, m47, which had an approximately 1,000-fold lower potency than wild-type IL-3 prepared in the same manne9'; or LPS. No increase in cell-surface Pselectin expression was observed using either the mutant IL-3, TNFa, or LPS ( Table 2) . Thrombin alone added for 24 hours or 48 hours did not induce cell surface P-selectin expression (data not shown). The inclusion of 10 or 100 pg r d " polymyxin B with IL-3 also did not significantly alter the increase in P-selectin expression induced by IL-3 ( Table  2) . Polymyxin B at 10 pg rd" inhibited the induction of E-selectin expression by LPS (1 pg rd") by 70%, and at 100 pg mI", E-selectin expression induced by LPS was completely inhibited (data not shown).
Additive effect of thrombin and IL-3 in upregulating cellsugace P-selectin expression. The time course of thrombin-induced cell-surface P-selectin expression on HUVEC pretreated with IL-3 was parallel to that observed in H W E C Time after thrombin addition (h) that had not been previously exposed to IL-3; ie, P-selectin expression peaked at 10 minutes after thrombin addition and declined after 30 minutes (Fig 4) . The absolute level of Pselectin expression, however, was higher in cells pretreated with IL-3 at all time points after thrombin addition. At the peak of thrombin stimulation (10 minutes), the level of Pselectin expression induced by thrombin after 48 hours of IL-3 pretreatment was significantly higher than that obtained with either stimulus alone.
Time course of P-selectin mRNA induction by IL-3. To determine whether IL-3 induced solely the degranulation of Weibel-Palade bodies that led to the increase in cell-surface expression of P-selectin, we also examined the effect of IL-3 on the steady-state level of P-selectin mRNA in HUVEC. We found that the P-selectin mRNA was also increased by IL-3 (Fig 5) , but unlike the upregulation of cell-surface Pselectin expression, IL-3 induced an increase in mRNA only after 16 hours of IL-3 stimulation (Fig 5A and B) . Like the increase in cell-surface expression observed at 48 hours, the mean (kSEM) fold induction in P-selectin mRNA expression above basal was 1.92 5 0.22 (P < .05; n = 4) and was also prolonged, lasting at least 96 hours (Fig 5A) . The RNase protection probe used also detected the transmembrane-lacking forms of P-selectin mRNA, with expected bands of 229 and 73 bases. However, the protected fragment of 73 bases did not migrate as a discrete band and, hence, appeared less intense than expected. This is probably due to the possibility of stem-loop formation in the vector sequences at the 3' end of the cRNA probe that is resistant to complete digestion, resulting in fragments of varying lengths rather than a fragment of discrete length. The data showed that the mRNA use only.
For personal at PENN STATE UNIVERSITY on February 22, 2013. bloodjournal.hematologylibrary.org From for the transmembrane-lacking form also responded in the same way to IL-3 as the transmembrane-containing forms (Fig 5B) .
DISCUSSION
In this report, we have shown that IL-3 upregulated the expression of P-selectin, a key determinant in leukocyte rolling and adherence, on the surface of HUVEC, thus further substantiating its role as an immune cytokine. Importantly, IL-3 induced not only an acute phase of P-selectin expression, which had previously been documented with other stimuli, but it also induced a prolonged late-phase P-selectin expression that is novel. The late-phase P-selectin expression lasted at least 4 days after the addition of IL-3 and was concomitant with an increase in the steady-state level of Pselectin mRNA over the same period. Upregulation of Pselectin mRNA by IL-3 is another novel observation, as previously known inducers of P-selectin expression on HU-VEC did not alter steady-state P-selectin mRNA levels. We speculate that upregulation of steady-state P-selectin mRNA level may be required to maintain the prolonged increase in cell-surface expression.
-
The prolonged late-phase induction of P-selectin expression by IL-3 appeared to be specific to IL-3 based on the following criteria. A recombinant mutant form of L 3
1.6 -(m47), TNFa (a known activator of endothelial cells), and
LPSz3 and thrombin (both previously shown to be acute inducers of cell-surface P-selectin expression) did not induce P-selectin expression when added to HUVEC for 48 hours.
Moreover, a MoAb to the IL3R a-chain was able to partially induction of P-selectin expression by IL-3, suggesting that the effect is not likely to be mediated by endotoxin and that the induction does not require priming by endotoxin. Although IL-3 increases E-selectin expression at 4 hours, no chronic upregulation of E-selectin or vascular cell adhesion molecule 1 (VCAM-l) has been observed (J.R.G., unpublished observations, September 1993). It has previously been established that the rapid upregulation of cell-surface P-selectin expression on HUVEC after stimulation by agents such as PMA or histamine is due to -229b l " ( -) Fig 5. (A) Time course of IL-3-induced, steady-state P-selectin mRNA expreuion on HUMC. HUVEC were plated and stimulated with IL-3 as described in Fig 1. P-selectin mRNA levels were determined using an RNase protection assay and normalized t o the calculated as P-se1ectin:GAPDH at time t/basal P-se1ectin:GAPDH.
Each point represents the mean of two experiments. (Inset) Mean fold induction of P-selectin mRNA in the first 2 hours after IL-3 addition. (B) RNase protection gel showing protected fragments from transmembrane domain-containing forms of P-selectin (P sell, the transmembrane-lacking form [229b TM(-) and 73b TMt-11, and GAPDH bands without or with IL-3 added for 48 hours. The data are from one representative experiment of four, and the ratio of Pse1ectin:GAPDH (P sel:GAPDH) mRNA as quantified using a phosphorimager is shown below each lane. The molecular weight (MW) markers used were =P-labeled pUC19IHpa II DNA, and the sizes of the bands are indicated on the left. Both the P-selectin and GAPDH -GAPDH use only.
For personal at PENN STATE UNIVERSITY on February 22, 2013. bloodjournal.hematologylibrary.org From translocation to the plasma membrane and subsequent degranulation of Weibel-Palade bodies, the storage granules of P-selectin in HUVEC." It, therefore, follows that the rapid induction of cell-surface P-selectin after the addition of IL-3 was likely to be due also to degranulation of WeibelPalade bodies.
An intriguing question arising from our observation that IL-3 also induced a later prolonged cell-surface upregulation of P-selectin expression is the mechanism by which this occurs. The concomitant increase in P-selectin mRNA induced by IL-3 suggests that de novo protein synthesis may be necessary. Consequently, an excess of P-selectin protein may be produced compared with basal levels, which may have two possible fates. The excess protein may be packaged into Weibel-Palade bodies and translocated to the cell surface as normal, or the excess protein synthesized may saturate the storage pathway and be exported directly to the plasma membrane. The observation that thrombin added for 10 minutes after stimulating HUVEC for 48 hours with IL-3 resulted in a further increase in cell-surface P-selectin expression suggests that different signaling pathways for 48-hour IL-3 and thrombin induction may exist. The signaling pathway induced by 48 hours of IL-3 may result in degranulation of a different subset of Weibel-Palade bodies from that induced by thrombin or may lead to a completely different pathway of export.
The prolonged increase in P-selectin expression also poses the question of the half-life (tIl2) of P-selectin on the cell surface after prolonged IL-3 treatment. P-selectin expression induced by agents such as thrombin and histamine is normally rapidly reabsorbed into the cell. However, it is not known whether P-selectin on the cell-surface after prolonged IL-3 treatment is turned over at the same rate. Prolonged cellsurface P-selectin expression may, therefore, be the result of continuous output of P-selectin to the cell surface or, it may be the result of an increase in the tllZ of the molecule on the cell-surface. The similarly rapid loss of P-selectin from the cell surface after thrombin stimulation in HUVEC that had been exposed to IL-3 for 48 hours compared with resting HUVEC suggests that there is not an overall increase in the tIl2 of cell-surface P-selectin; otherwise, the increase in Pselectin expression induced by thrombin plus IL-3 would be less transient. However, our currently available data cannot rule out the possibility that IL-3 induces a different isoform with a longer t1,2.
So far, upregulation of P-or E-selectin on the surface of endothelium by known proinflammatory molecules only results in transient expression of these two selectins. This does not correlate with the long term increase in P-or Eselectin expression observed in vivo in certain chronic inflammatory diseases such as rheumatoid arthritis,'' Graves disease,26 and allergic rhinitis:' where increased cell-surface P-selectin expression have been observed. Our results represent the first in vitro observation of prolonged or chronic Pselectin expression on HUVEC. Together with the observations that IL-3 is a product of activated T lymphocytes and that progression from acute to chronic inflammation also includes T lymphocyte infiltration before subsequent monocyte infiltration, our observations may have important implications for the establishment and maintenance of chronic inflammatoIy diseases.
